Skip to main content
. 2020 Jul 24;85:104474. doi: 10.1016/j.meegid.2020.104474

Fig. 3.

Fig. 3

The proposed workflow to select the most proper SARS-CoV-2 derived CPP candidates as intracellular delivery vectors.